Report for Mao F

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (12)

Title : Anti-Ovarian cancer potential, in silico studies and anti-alzheimer's disease effects of some natural compounds as cholinesterase inhibitors - Fu_2022_Biotechnol.Appl.Biochem__
Author(s) : Fu M , Ji C , Yang T , Mao F , Shati AA , El-Kott AF , El-Maksoud MMA , Negm S , Ji Y
Ref : Biotechnol Appl Biochem , : , 2022
Abstract : Fu_2022_Biotechnol.Appl.Biochem__
ESTHER : Fu_2022_Biotechnol.Appl.Biochem__
PubMedSearch : Fu_2022_Biotechnol.Appl.Biochem__
PubMedID: 36515452

Title : The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression - Li_2021_Eur.J.Med.Chem_229_114045
Author(s) : Li X , Li J , Huang Y , Gong Q , Fu Y , Xu Y , Huang J , You H , Zhang D , Mao F , Zhu J , Wang H , Zhang H
Ref : Eur Journal of Medicinal Chemistry , 229 :114045 , 2021
Abstract : Li_2021_Eur.J.Med.Chem_229_114045
ESTHER : Li_2021_Eur.J.Med.Chem_229_114045
PubMedSearch : Li_2021_Eur.J.Med.Chem_229_114045
PubMedID: 34922191

Title : Discovery of nitazoxanide-based derivatives as autophagy activators for the treatment of Alzheimer's disease - Li_2020_Acta.Pharm.Sin.B_10_646
Author(s) : Li X , Lu J , Xu Y , Wang J , Qiu X , Fan L , Li B , Liu W , Mao F , Zhu J , Shen X , Li J
Ref : Acta Pharm Sin B , 10 :646 , 2020
Abstract : Li_2020_Acta.Pharm.Sin.B_10_646
ESTHER : Li_2020_Acta.Pharm.Sin.B_10_646
PubMedSearch : Li_2020_Acta.Pharm.Sin.B_10_646
PubMedID: 32322468

Title : Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer's Disease Agents - Xu_2019_ACS.Chem.Neurosci_10_482
Author(s) : Xu Y , Zhang J , Wang H , Mao F , Bao K , Liu W , Zhu J , Li X , Zhang H , Li J
Ref : ACS Chem Neurosci , 10 :482 , 2019
Abstract : Xu_2019_ACS.Chem.Neurosci_10_482
ESTHER : Xu_2019_ACS.Chem.Neurosci_10_482
PubMedSearch : Xu_2019_ACS.Chem.Neurosci_10_482
PubMedID: 30110536

Title : Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease - Mao_2018_ACS.Chem.Neurosci_9_328
Author(s) : Mao F , Wang H , Ni W , Zheng X , Wang M , Bao K , Ling D , Li X , Xu Y , Zhang H , Li J
Ref : ACS Chem Neurosci , 9 :328 , 2018
Abstract : Mao_2018_ACS.Chem.Neurosci_9_328
ESTHER : Mao_2018_ACS.Chem.Neurosci_9_328
PubMedSearch : Mao_2018_ACS.Chem.Neurosci_9_328
PubMedID: 29068218

Title : Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) - Ni_2018_ACS.Chem.Neurosci_9_1625
Author(s) : Ni W , Wang H , Li X , Zheng X , Wang M , Zhang J , Gong Q , Ling D , Mao F , Zhang H , Li J
Ref : ACS Chem Neurosci , 9 :1625 , 2018
Abstract : Ni_2018_ACS.Chem.Neurosci_9_1625
ESTHER : Ni_2018_ACS.Chem.Neurosci_9_1625
PubMedSearch : Ni_2018_ACS.Chem.Neurosci_9_1625
PubMedID: 29616790

Title : Novel Vilazodone-Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation - Li_2017_ACS.Chem.Neurosci_8_2708
Author(s) : Li X , Wang H , Xu Y , Liu W , Gong Q , Wang W , Qiu X , Zhu J , Mao F , Zhang H , Li J
Ref : ACS Chem Neurosci , 8 :2708 , 2017
Abstract : Li_2017_ACS.Chem.Neurosci_8_2708
ESTHER : Li_2017_ACS.Chem.Neurosci_8_2708
PubMedSearch : Li_2017_ACS.Chem.Neurosci_8_2708
PubMedID: 28872831

Title : Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents - Li_2016_J.Med.Chem_59_8326
Author(s) : Li X , Wang H , Lu Z , Zheng X , Ni W , Zhu J , Fu Y , Lian F , Zhang N , Li J , Zhang H , Mao F
Ref : Journal of Medicinal Chemistry , 59 :8326 , 2016
Abstract : Li_2016_J.Med.Chem_59_8326
ESTHER : Li_2016_J.Med.Chem_59_8326
PubMedSearch : Li_2016_J.Med.Chem_59_8326
PubMedID: 27552582

Title : Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease - Mao_2015_J.Enzyme.Inhib.Med.Chem_30_995
Author(s) : Mao F , Li J , Wei H , Huang L , Li X
Ref : J Enzyme Inhib Med Chem , 30 :995 , 2015
Abstract : Mao_2015_J.Enzyme.Inhib.Med.Chem_30_995
ESTHER : Mao_2015_J.Enzyme.Inhib.Med.Chem_30_995
PubMedSearch : Mao_2015_J.Enzyme.Inhib.Med.Chem_30_995
PubMedID: 25792506

Title : New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol - Mao_2014_Org.Biomol.Chem_12_5936
Author(s) : Mao F , Yan J , Li J , Jia X , Miao H , Sun Y , Huang L , Li X
Ref : Org Biomol Chem , 12 :5936 , 2014
Abstract : Mao_2014_Org.Biomol.Chem_12_5936
ESTHER : Mao_2014_Org.Biomol.Chem_12_5936
PubMedSearch : Mao_2014_Org.Biomol.Chem_12_5936
PubMedID: 24986600

Title : Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity - Mao_2013_Bioorg.Med.Chem.Lett_23_6737
Author(s) : Mao F , Chen J , Zhou Q , Luo Z , Huang L , Li X
Ref : Bioorganic & Medicinal Chemistry Lett , 23 :6737 , 2013
Abstract : Mao_2013_Bioorg.Med.Chem.Lett_23_6737
ESTHER : Mao_2013_Bioorg.Med.Chem.Lett_23_6737
PubMedSearch : Mao_2013_Bioorg.Med.Chem.Lett_23_6737
PubMedID: 24220172

Title : O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-beta aggregation - Mao_2012_Bioorg.Med.Chem_20_5884
Author(s) : Mao F , Huang L , Luo Z , Liu A , Lu C , Xie Z , Li X
Ref : Bioorganic & Medicinal Chemistry , 20 :5884 , 2012
Abstract : Mao_2012_Bioorg.Med.Chem_20_5884
ESTHER : Mao_2012_Bioorg.Med.Chem_20_5884
PubMedSearch : Mao_2012_Bioorg.Med.Chem_20_5884
PubMedID: 22944335